[Analysis of M phase using flow cytometry and its application to chemosensitivity tests]. 1988

Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
Ist Dept. of Surgery, Nagasaki University School of Medicine.

UI MeSH Term Description Entries
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
March 2003, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
May 2007, Cytometry. Part B, Clinical cytometry,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
September 2005, Zhonghua nan ke xue = National journal of andrology,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
March 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
April 1996, Journal of clinical pathology,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
December 1996, Hematology and cell therapy,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
April 1988, Nihon rinsho. Japanese journal of clinical medicine,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
January 1990, Methods in enzymology,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
July 1987, Journal of immunological methods,
Y Tagawa, and K Miyashita, and T Sato, and H Ishikawa, and H Tashiro, and Y Mine, and K Kajiwara, and T Kunisaki, and M Yokota, and M Tomita
July 2015, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!